2012
DOI: 10.1111/j.1651-2227.2012.02671.x
|View full text |Cite
|
Sign up to set email alerts
|

Duration and morbidity of chronic immune thrombocytopenic purpura in children: five‐year follow‐up of a Nordic cohort

Abstract: In a Nordic cohort of children with chronic ITP, one half had recovered 5 years after diagnosis, more than half never required hospitalization and <10% experienced serious bleeding episodes, always with a platelet count <20 × 10(9) /L. Aggressive management can be restricted to the minority of children with continuing severe thrombocytopenia and frequent, clinically significant bleeding events.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

2
36
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(39 citation statements)
references
References 33 publications
2
36
1
Order By: Relevance
“…Information on long‐term outcomes and clinically predictive factors for disease remission of chronic ITP in children is scarce and what studies have been done have reported varying results . There are no definite clinical parameters for predicting clinical outcome or remission, since all studies, including ours, had limitations due to the retrospective study design .…”
Section: Discussionmentioning
confidence: 87%
See 2 more Smart Citations
“…Information on long‐term outcomes and clinically predictive factors for disease remission of chronic ITP in children is scarce and what studies have been done have reported varying results . There are no definite clinical parameters for predicting clinical outcome or remission, since all studies, including ours, had limitations due to the retrospective study design .…”
Section: Discussionmentioning
confidence: 87%
“…Information on long-term outcomes and clinically predictive factors for disease remission of chronic ITP in children is scarce and what studies have been done have reported varying results. 9,11,12 There are no definite clinical parameters for predicting clinical outcome or remission, since all studies, including ours, had limitations due to the retrospective study design. 10 However, our study was long-term (over 38 years) and included 113 children with chronic ITP who were followed up for a median duration of almost 6 years (range 0.5-24 years) and had a median time to remission of 7.1 years (95% CI: 4.8-11.0).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…in chronic ITP. Rosthoi et al [7] observed a spontaneous recovery within 3 months in less than 5% of the children, and within 2 years, in 35% of the children. Similarly, Coccia et al [8] report a spontaneous remission rate of 42.8% within a period of 9-90 months, and calculate a probability of spontaneous remission of 24% at 4 years and of 50% at 8 years.…”
Section: Discussionmentioning
confidence: 99%
“…However, approximately, 20-30% of children have persistent thrombocytopenic states for more than 6-12 months, which is called chronic ITP with increasing risk of bleeding (5,6). Fortunately, 30-60% of chronic childhood ITP patients regains normal platelet count and gets spontaneous remission within 5 years from initial diagnosis (7). IL-10 is an important immunoregulatory cytokine with mainly an anti-inflammatory role in the immune system.…”
mentioning
confidence: 99%